Page 59 - TD-2-3
P. 59

Tumor Discovery                                                          Pleuropulmonary blastoma in child



            left-sided chest tube was removed on the 4  post-operative   mass (Figure  4B). In the hospital, we worked with the
                                             th
            day, while the right-sided chest tube was removed on the   medical oncology team to stabilize the patient’s condition
            6  day after expansion of the right lung, and no drainage was   at the time, but to no avail, he succumbed within 2 days of
             th
            performed. Post-operative chest X-ray showed complete   admission.
            expansion of a previously collapsed right lung. A repeat
            chest CT scan showed clear bilateral lung zones with no   3. Discussion
            evidence  of  recurrence  or  metastasis  (Figure  4A).  The   PPB is a rare embryonal thoracic tumor. It is highly
            clamshell incision wound was well healed, and the patient   aggressive by nature, arising from both lung and pleura, and
            was healthy at discharge on the 9  post-operative day. He   accounting for 0.5% of all primary malignant lung tumors
                                       th
            had been planned for doxorubicin-based chemotherapy   in the pediatric population. Three types of PBBs have been
            treatment and genetic testing of DICER1, but his parents   described in the literature. Type  I PBB is purely cystic;
            and family members were unwilling to send the patient for   type II comprises cystic and solid elements; and type III is
            further testing, intervention, and treatment. After 87 days   exclusively solid. It is solely confined to the pediatric age
            of surgery, he was sent back to the hospital due to severe   group, specifically restricted to children under 7 years of
            respiratory distress with a recurrence of gross mediastinal   age according to most reports . In 2009, a heterozygous
                                                                                       [2]
                                                               germline mutation in DICER1 was identified as the first
                                                               identified genetic cause in the majority of documented PPB
                                                               cases. The DICER1 gene located on human chromosome
                                                               14 instructs cells to make a protein called DICER1, which
                                                               processes molecules to make microRNA. This germline
                                                               mutation in DICER1 can lead to a unique hereditary cancer
                                                               predisposition syndrome, which is accompanied by PPB,
                                                               cystic nephroma, ovarian Sertoli-Leydig cell tumors, ciliary
                                                               body medulloepithelioma, nodular hyperplasia, pituitary
                                                               blastoma, pineoblastoma, nasal chondromesenchymal
                                                               hamartoma, and differentiated carcinoma of the thyroid
                                                               gland. However, a review of 350 confirmed PPB cases
                                                               by Messinger et al. confirmed that there were no clinical
                                                               differences in terms of germline  DICER1 mutation and
                                                               thus no distinct prognostic value .
                                                                                         [3]
                                                                 Type  I tumors (median age at diagnosis: 8  months)
            Figure  2. Intraoperative picture showing a healthy left lung, intact
            pericardium, and compressed right-sided lung upper and middle lobes   have minimal malignant components and are mostly
            after tumor removal. The inset shows the resected tumor mass.  benign. They may change to type  II or type  III tumors.

                         A                         B                     C








                         D                         E                     F









            Figure 3. Histopathological findings. (A) Blastemal and sarcomatous cells (hematoxylin-eosin staining, ×400 magnification). (B) Pleomorphic anaplastic
            cells in sarcomatous areas (hematoxylin-eosin staining, ×400). (C) Rhabdomyoblasts in the blastemal areas (hematoxylin-eosin staining, ×400). (D) Low-
            grade fetal adenocarcinoma component (hematoxylin-eosin staining, ×400). (E) Tumor cells showing cytoplasmic immunoreactivity for vimentin in
            blastemal areas (vimentin staining, ×400). (F) Rhabdomyoblasts in tumor cells showing desmin immunoreactivity (desmin staining, ×400).



            Volume 2 Issue 3 (2023)                         3                          https://doi.org/10.36922/td.1756
   54   55   56   57   58   59   60   61   62   63   64